Chief, Hematology Oncology Yale School of Medicine | New Haven, Connecticut We are pleased to announce that Yale School of Medicine has named Ian E. Krop, MD, PhD, as Section Chief of Medical Oncology and Hematology and Deputy Director for Clinical Affairs for Yale Cancer Center and Smilow Cancer Hospital. Dr. Krop is an international leader in breast cancer care and clinical investigation. He joined Yale in 2022 and quickly became a trusted physician-leader and valued partner across Yale School of Medicine and the Yale New Haven Health System. He is widely recognized for his collaborative leadership approach and focus on quality, safety, and innovation in cancer care.Krop has served as Chief Clinical Research Officer and Medical Director of the Clinical Trials Office for Yale Cancer Center for the last four years. As Section Chief and Deputy Director, Krop will provide broad strategic and operational leadership for the medical oncology and hematology program in the Department of Medicine and across Yale Cancer Center and all Smilow Cancer Hospital locations.Prior to joining Yale, Dr. Krop was at Dana-Farber Cancer Institute for 20 years where he focused on drug development in breast cancer. Nationally, he serves as Chief Scientific Officer for the Translational Breast Cancer Research Consortium.Dr. Krop earned his bachelor’s degree, his medical degree, and a PhD in Biochemistry, Cellular and Molecular Biology from Johns Hopkins’ University. You can view the full announcement about his appointment here.
